Apparent suppression of MMP-9 activity by GD1a as determined by gelatin zymography

Biochemical and Biophysical Research Communications

Volumn 349, Issue 1, 2006, Pages 426-431

  Hu, Dan ^a   Tan, Xuan ^a   Sato, Toshinori ^b   Yamagata, Sadako ^a   Yamagata, Tatsuya ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Ganglioside; GD1a; Metastasis; MMP 2; MMP 9; Zymography

Indexed keywords

GANGLIOSIDE GD 1A; GELATINASE B; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ELECTROPHORESIS; ENZYME BINDING; ENZYME DEGRADATION; ENZYME REPRESSION; GENETIC TRANSCRIPTION; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; CATTLE; CELL LINE, TUMOR; CULTURE MEDIA, CONDITIONED; GANGLIOSIDES; GELATIN; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; P38 MITOGEN-ACTIVATED PROTEIN KINASES; TIME FACTORS;

EID: 33748291573     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.08.062     Document Type: Article

References (18)

1. Curran S., and Murray G.I. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur. J. Cancer 36 (2000) 1621-1630
2. Klein G., Vellenga E., Fraaije M.W., Kamps W.A., and de Bont E.S.J.M. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia. Crit. Rev. Oncol./Hematol. 50 (2004) 87-100
3. Rundhaug J.E. Matrix metalloproteinases and angiogenesis. J. Cell. Mol. Med. 9 (2005) 267-285
4. Liotta L.A., and Stetler-Stevenson W.G. Tumor invasion and metastasis: an importance of positive and negative regulation. Cancer Res. 51 (1991) 5054-5059
5. D. Hu, Z. Man, T. Xuan, P. Wang, T. Takaku, S. Hyuga, X.S. Yao, T. Sato, S. Yamagata, T. Yamagata, Ganglioside GD1a regulation of matrix metalloproteinase-9 (MMP-9) expression in mouse FBJ cell Lines: GD1a suppression of MMP-9 expression stimulated by PI3K-Akt and p38 though not by the Erk signaling pathway, 2006, Submitted for publication.
6. Hyuga S., Yamagata S., Takatsu Y., Hyuga M., Nakanishi H., Furukawa K., and Yamagata T. Suppression of FBJ-LL cell adhesion to vitronectin by ganglioside GD1a and loss of metastatic capacity. International J. Cancer 83 (1999) 685-691
7. Yamagata S., Tanaka R., Ito Y., and Shimizu S. Gelatinase of murine metastatic tumor cells. Biochem. Biophys. Res. Commun. 158 (1989) 228-234
8. Yamagata S., Yoshii Y., Suh J.G., Tanaka R., and Shimizu S. Occurrence of an active form of gelatinase in human gastric and colorectal carcinoma tissues. Cancer Lett. 59 (1991) 51-55
9. Tamakoshi K., Kikkawa F., Nawa A., Ishikawa H., Mizuno K., Tamakoshi A., Yamagata S., Suganuma N., and Tomoda Y. Characterization of extracellular matrix-degrading proteinase and its inhibitor in gynecologic cancer tissues with clinically different metastatic form. Cancer 76 (1995) 2565-2571
10. Hamaguchi M., Yamagata S., Thant A.A., Xiao H., Iwata H., Mazaki T., and Hanafusa H. Augmentation of metalloproteinase (gelatinase) activity secreted from Rous sarcoma virus-infected cells correlates with transforming activity of src. Oncogene 10 (1995) 1037-1043
11. Miura R.O., Yamagata S., Miura Y., Harada T., and Yamagata T. Analysis of glycosaminoglycan-degrading enzymes by substrate gel electrophoresis (zymography). Anal. Biochem. 225 (1995) 333-340
12. Cao M., Sahmi M., Lussier J.G., and Price C.A. Plasminogen activator and serine protease inhibitor-E2 (protease nexin-1) expression by bovine granulosa cells in vitro. Biol. Reprod. 71 (2004) 887-893
13. Hattori S., Fujisaki H., Kiriyama T., Yokoyama T., and Irie S. Real-time zymography and reverse zymography: a method for detecting activities of matrix metalloproteinases and their inhibitors using FITC-labeled collagen and casein as substrates. Anal. Biochem. 301 (2002) 27-34
14. Kjeldsen L., Johnsen A.H., Sengeløv H., and Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J. Biol. Chem. 268 (1993) 10425-10432
15. Makowskia G.S., and Ramsby M.L. Zymographic analysis of latent and activated forms of matrix metalloproteinase-2 and -9 in synovial fluid: correlation to polymorphonuclear leukocyte infiltration and in response to infection. Clin. Chim. Acta 329 (2003) 77-81
16. Hu J., Zhang X., Nothnick W.B., and Spencer T.E. Matrix metalloproteinases and their tissue inhibitors in the developing neonatal mouse uterus. Biol. Reprod. 71 (2004) 1598-1604
17. Stamenkovic I. Matrix metalloproteinases in tumor invasion and metastasis. Cancer Biol. 10 (2000) 415-433
18. Brew K., Dinakarpandian D., and Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim. Biophys. Acta 1477 (2000) 267-283